HEADER TRANSFERASE 27-JUL-10 3O51 TITLE CRYSTAL STRUCTURE OF ANTHRANILAMIDE 10 BOUND TO AURORAA COMPND MOL_ID: 1; COMPND 2 MOLECULE: CDNA FLJ58295, HIGHLY SIMILAR TO SERINE/THREONINE-PROTEIN COMPND 3 KINASE 6; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: AURORAA KINASE DOMAIN (UNP RESIDUES 57 TO 323); COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS AURORAA, KINASE DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.HUANG REVDAT 3 21-FEB-24 3O51 1 REMARK REVDAT 2 06-APR-11 3O51 1 JRNL REVDAT 1 18-AUG-10 3O51 0 JRNL AUTH V.J.CEE,L.B.SCHENKEL,B.L.HODOUS,H.L.DEAK,H.N.NGUYEN, JRNL AUTH 2 P.R.OLIVIERI,K.ROMERO,A.BAK,X.BE,S.BELLON,T.L.BUSH, JRNL AUTH 3 A.C.CHENG,G.CHUNG,S.COATS,P.M.EDEN,K.HANESTAD,P.L.GALLANT, JRNL AUTH 4 Y.GU,X.HUANG,R.L.KENDALL,M.H.LIN,M.J.MORRISON,V.F.PATEL, JRNL AUTH 5 R.RADINSKY,P.E.ROSE,S.ROSS,J.R.SUN,J.TANG,H.ZHAO,M.PAYTON, JRNL AUTH 6 S.D.GEUNS-MEYER JRNL TITL DISCOVERY OF A POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE JRNL TITL 2 PYRIDINYL-PYRIMIDINE PHTHALAZINE AURORA KINASE INHIBITOR. JRNL REF J.MED.CHEM. V. 53 6368 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20684549 JRNL DOI 10.1021/JM100394Y REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 5132 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.288 REMARK 3 FREE R VALUE : 0.304 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1975 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3O51 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1000060673. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5132 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M (NH4)2HPO4, 20% PEG3350, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.37650 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.32900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.32900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.18825 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.32900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.32900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 57.56475 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.32900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.32900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 19.18825 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.32900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.32900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 57.56475 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 38.37650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 125 REMARK 465 GLY A 276 REMARK 465 TRP A 277 REMARK 465 SER A 278 REMARK 465 VAL A 279 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 CYS A 290 REMARK 465 GLY A 291 REMARK 465 THR A 292 REMARK 465 LYS A 389 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 126 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 162 CG CD CE NZ REMARK 470 ARG A 179 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 250 CG CD CE NZ REMARK 470 ARG A 251 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 255 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 304 CG CD NE CZ NH1 NH2 REMARK 470 MET A 305 CG SD CE REMARK 470 TYR A 334 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 335 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 141 -160.43 -120.19 REMARK 500 LYS A 156 15.85 49.61 REMARK 500 LYS A 171 7.71 -65.15 REMARK 500 VAL A 174 29.76 -142.78 REMARK 500 SER A 226 -49.28 61.31 REMARK 500 LYS A 250 21.97 -75.66 REMARK 500 ARG A 255 -115.51 -92.88 REMARK 500 ALA A 267 36.37 -85.60 REMARK 500 MET A 305 -70.17 -70.56 REMARK 500 VAL A 344 70.73 44.51 REMARK 500 LEU A 364 59.93 -95.48 REMARK 500 GLU A 379 57.23 -107.18 REMARK 500 PRO A 381 -49.18 -27.42 REMARK 500 THR A 384 7.13 -65.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LJF A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3O50 RELATED DB: PDB DBREF 3O51 A 125 391 UNP B4DX16 B4DX16_HUMAN 57 323 SEQRES 1 A 267 LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY ARG SEQRES 2 A 267 PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU ALA SEQRES 3 A 267 ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS VAL SEQRES 4 A 267 LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU HIS SEQRES 5 A 267 GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU ARG SEQRES 6 A 267 HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS ASP SEQRES 7 A 267 ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO LEU SEQRES 8 A 267 GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS PHE SEQRES 9 A 267 ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU ALA SEQRES 10 A 267 ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE HIS SEQRES 11 A 267 ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER ALA SEQRES 12 A 267 GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL HIS SEQRES 13 A 267 ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR LEU SEQRES 14 A 267 ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET HIS SEQRES 15 A 267 ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU CYS SEQRES 16 A 267 TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA ASN SEQRES 17 A 267 THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL GLU SEQRES 18 A 267 PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG ASP SEQRES 19 A 267 LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN ARG SEQRES 20 A 267 PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE THR SEQRES 21 A 267 ALA ASN SER SER LYS PRO SER HET LJF A 1 38 HETNAM LJF N-[4-({3-[5-FLUORO-2-(METHYLIDENEAMINO)PYRIMIDIN-4- HETNAM 2 LJF YL]PYRIDIN-2-YL}OXY)PHENYL]-2-(PHENYLAMINO)BENZAMIDE FORMUL 2 LJF C29 H21 F N6 O2 HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 LYS A 171 1 6 HELIX 3 3 VAL A 174 SER A 186 1 13 HELIX 4 4 THR A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 LYS A 250 1 22 HELIX 6 6 PRO A 297 GLU A 302 1 6 HELIX 7 7 LYS A 309 GLY A 325 1 17 HELIX 8 8 THR A 333 ARG A 343 1 11 HELIX 9 9 THR A 353 LEU A 364 1 12 HELIX 10 10 ASN A 367 ARG A 371 5 5 HELIX 11 11 MET A 373 GLU A 379 1 7 HELIX 12 12 TRP A 382 ASN A 386 5 5 SHEET 1 A 5 PHE A 133 LYS A 141 0 SHEET 2 A 5 ASN A 146 GLU A 152 -1 O LEU A 149 N GLY A 136 SHEET 3 A 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 A 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 A 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 B 2 LEU A 262 LEU A 264 0 SHEET 2 B 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 CISPEP 1 GLY A 142 LYS A 143 0 -0.85 SITE 1 AC1 17 LEU A 139 LYS A 141 PHE A 144 VAL A 147 SITE 2 AC1 17 LEU A 164 LEU A 178 GLU A 181 GLN A 185 SITE 3 AC1 17 LEU A 196 LEU A 208 LEU A 210 GLU A 211 SITE 4 AC1 17 TYR A 212 ALA A 213 LEU A 263 ALA A 273 SITE 5 AC1 17 PHE A 275 CRYST1 86.658 86.658 76.753 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011540 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011540 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013029 0.00000